A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S. Food ...

Difficulty peeing, a frequent need to go to the toilet and trouble emptying their bladder - those are just some of the problems living with an enlarged prostate can bring men. Just ask David Fleming, ...

Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections—but with fewer of the worst ...

DEAR DR. ROACH: I am a 68-year-old male who weighs 130 pounds and is 5 feet, 7 inches tall. I am in good shape and work out regularly. I had my prostate removed in 2023 after about six years of active ...

As soon as they cross the age of 40, most men start facing a common problem, which is a prostate problem. This problem is increasing rapidly everywhere, from cities to villages. People visit doctors, ...

DEAR DR. ROACH: I am 71 and began having urinary issues due to benign prostatic hyperplasia many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn’t provide any ...

The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily?

Because AGA typically presents decades before the first symptoms of BPH, Arias-Santiago and colleagues suggest that early-onset AGA may be a useful marker for BPH risk later in life. To test this ...

An experimental new treatment slows down the spread of metastatic prostate cancer, postponing the use of hormone treatment by ...

Cognitive impairment can occur in cancer patients who are treated with a variety of therapies, including radiation therapy, hormone therapy, and chemotherapy. After chemotherapy treatment it is ...

The prostate gland has become another major concern of many Nigerian men today, after hypertension, heart and colon questions. The gland is either inflamed, enlarged or cancerous in many cases. Among ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...